APDA COVID-19 INFORMATION & RESOURCES: The American Parkinson Disease Association (APDA) continues to monitor the COVID-19 situation, particularly as...see more it relates to our Parkinson’s disease (PD) community. This page is updated regularly as new information becomes available. Vaccines: Three COVID-19 vaccines have been approved for use in the United States — one manufactured by Pfizer/BioNTech, […]

Read More

The American Parkinson Disease Association (APDA) is a proud partner of the 26th Annual Parkinson’s Unity Walk taking place on...see more Saturday, April 25, 2020 in Central Park, New York City. 100% of donations raised by the event will go to research funded by the leading PD foundations, including APDA. In addition to raising awareness and funds […]

Read More

Deep brain stimulation (DBS) is a surgical treatment for Parkinson’s disease (PD) symptoms in...see more which small wires are inserted deep into the brain to deliver electrical current that allows for maintenance of more normal movement. DBS is particularly helpful for those with medication-resistant tremors as well as for those who […]

Read More

Building off of pivotal APDA-funded work highlighted...see more here, Dr. J. Timothy Greenamyre and his team, published a new study  investigating the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease (PD). LRRK2 is known to be mutated in a small […]

Read More

Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi  had just spent the day learning about health care disparities in PD care, low […]

Read More